www.nytimes.com
1 month agoMedicine
Opinion | How Psychedelic Research Got High on Its Own Supply
Lykos Therapeutics faced a significant setback with the F.D.A.'s rejection of their MDMA PTSD treatment application, raising concerns about trial integrity. [ more ]